SOD1 and amyotrophic lateral sclerosis: Additionally, patient advocates have played a crucial role in the recent approval of Tofersen, an antisense oligonucleotide (ASO), for the treatment of ALS associated with a mutation in the superoxide dismutase 1 (SOD1) gene.